June 26, 2013
  • NSAIDs Risky Even in Short Term for Patients With
    Heart Disease

    Pharmacists might consider sounding an alarm when they see NSAIDs prescribed for patients with known heart disease. A new study presented at a European conference underscores the immediate risks of even short-term use of the drugs in patients with existing cardiovascular issues. Here is what the authors presented.

  • Restrictions Lifted on Sale of Plan B One-Step, Not Two-Pill Version

    Plan B One-Step will be moving from behind the counter, but some restrictions will remain in place for the two-pill formulation of the levonorgestrel-based emergency contraceptive. That's the ultimate result of a back-and-forth between the Obama Administration and the federal courts over the last several months. Find out the details.

  • Overcoming Resistance to VTE Prophylaxis in Hospitalized Patients

    Blood-thinner prophylaxis can be critical for preventing VTE in hospitalized patients, but patients don’t always receive all of the doses ordered. In fact, the rates of noncompliance can be as much as 30% in some units. A new Johns Hopkins study suggests the reasons for compliance issues and what can be done about them.

  • New Database Offers Pharmacists Easy Access to Supplement Labels

    Pharmacy customers have a lot of questions about dietary supplements, and, too often, pharmacists try to answer them while struggling to make out the fine print on the product labels. A new database from the National Institutes of Health offers an easier solution for about 17,000 dietary supplements. Here are the details as well as an additional tool pharmacists can recommend to customers.

U.S. Pharmacist Social Connect